All companies
Visit website
GENOMIC EXPRESSION
OperatingGenomic Expression Inc.
Healthcare · Technology · Founded 2009
Saving lives now, one cancer patient at a time
Valuation cap ⓘ
$50.0M
As of Feb 2025 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$125,032
Across 1 round since 2024
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its source$1.4M
$129K
2022
$608K
−$127K
2023
$223K
−$274K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
Income statement
Revenue
$1,368,461
$608,380
$222,724
Cost of goods sold
$325,973
$236,708
$0
Gross margin
76%
61%
100%
Net income
$128,549
-$127,064
-$274,187
Taxes paid
$0
$0
$0
Balance sheet
Cash
$234,379
$66,375
$61,239
Accounts receivable
$330,958
$349,138
$438,374
Total assets
$1,019,887
$1,076,741
$1,024,831
Short-term debt
$89,738
$201,198
$288,027
Long-term debt
$277,920
$337,217
$472,665
Total liabilities
$367,658
$538,415
$760,692
Other
Headcount
—
5
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$50.0M
Valuation cap
Reg CF Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $125K / $1.2MInvestors 76Valuation cap $50M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 1 of 2 annual reports (FY2024–FY2025)
76 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001611868
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.